PT01.2: ZP7570: A Novel GLP-1/GLP-2 Dual Acting Peptide with Potential as the Next Generation Therapy for Short Bowel Syndrome. (September 2019) - Skarbaliene, J.; Russell, W.; Griffin, J.; Eriksson, P.-O.